文献速递术前评估与围术期医学疼痛医学

无阿片麻醉方案对大型手术后早期恢复质量的影响:SOFA随机临床试验

Opioid-free Anesthesia Protocol on the Early Quality of Recovery after Major Surgery (SOFA Trial): A Randomized Clinical Trial.
PubMed 文献 · Anesthesiology · 2024-01-01

SOFA试验为单中心、随机、评估者与患者盲法的对照研究,纳入136例择期大型手术患者(排除骨科手术),比较无阿片麻醉方案(联合至少两种药物)与标准阿片麻醉对术后恢复质量的影响。主要结局为术后24小时QoR-15评分,无阿片组显著高于标准组(差异6.2,95%CI 0.4-12.0,P=0.026),48小时和72小时也显著差异,但其他次要结局无差异,无重大不良事件。结论认为无阿片方案在统计上但非临床上显著改善恢复质量。

要点

  • 无阿片麻醉组术后24小时QoR-15评分较标准组高6.2分(95%CI 0.4-12.0,P=0.026)。
  • 48小时和72小时QoR-15评分仍显著优于标准组,但差异临床意义有限。
  • 慢性疼痛和生活质量等次要结局无显著差异,无重大不良事件。

核心结论

  • 无阿片麻醉方案在统计上但非临床上显著改善择期大型手术后的早期恢复质量。

研究设计与样本

  • 单中心、随机、对照、评估者与患者盲法临床试验,从2021年7月10日至2022年2月12日进行。
  • 共随机136例患者,135例纳入主要分析(平均年龄45.9±15.7岁;116例女性[87.2%];85例大型整形手术[63.9%]),无阿片组67例,标准组68例。

主要发现

  • 术后24小时QoR-15评分:无阿片组114.9±15.2 vs 标准组108.7±18.1,差异6.2(95%CI 0.4-12.0,P=0.026)。
  • 术后48小时QoR-15差异8.7(95%CI 2.9-14.5,P=0.004),72小时差异7.3(95%CI 1.6-13.0,P=0.013)。
  • 其他次要结局(慢性疼痛发生率、3个月生活质量)无差异,未观察到重大不良事件。

临床怎么用

  • 对于择期大型手术(排除骨科手术),可考虑使用无阿片麻醉方案以轻度改善早期恢复质量。
  • 无阿片方案为联合至少两种药物(氯胺酮、利多卡因、可乐定、硫酸镁)而不使用阿片类药物。

局限性

  • 单中心研究,样本量较小(135例),且以女性及整形手术为主,外推性受限。
  • 恢复质量差异虽统计学显著但未达临床意义阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid-free anesthesia is increasingly being adopted to reduce opioid consumption, but its impact on early postoperative recovery after major surgery has not been evaluated in comparative trials. The hypothesis was that an opioid-free anesthesia protocol would enhance the early quality of recovery for patients undergoing scheduled major surgery under general anesthesia. METHODS: The SOFA study was a monocentric, randomized, controlled, assessor- and patient-blinded clinical trial conducted from July 10, 2021, to February 12, 2022. The eligible population included male and female patients undergoing scheduled major surgery, excluding bone procedures, that typically require opioids for postoperative pain management. Patients in the intervention group received a combination of at least two drugs among ketamine, lidocaine, clonidine, and magnesium sulfate, without opioids for anesthesia. The standard group received opioids. The primary outcome was early postoperative quality of recovery, assessed by Quality of Recovery-15 score at 24 h after surgery. Secondary outcomes were Quality of Recovery-15 at 48 and 72 h after surgery, incidence of chronic pain, and quality of life at 3 months. RESULTS: Of the 136 randomized patients, 135 were included in the primary analysis (mean age, 45.9 ± 15.7 yr; 116 females [87.2%]; 85 underwent major plastic surgery [63.9%]), with 67 patients in the opioid-free anesthesia group and 68 in the standard group. The mean Quality of Recovery-15 at 24 h was 114.9 ± 15.2 in the opioid-free anesthesia group versus 108.7 ± 18.1 in the standard group (difference, 6.2; 95% CI, 0.4 to 12.0; P = 0.026). Quality of Recovery-15 scores also differed significantly at 48 h (difference, 8.7; 95% CI, 2.9 to 14.5; P = 0.004) and at 72 h (difference, 7.3; 95% CI, 1.6 to 13.0; P = 0.013). There were no differences in other secondary outcomes. No major adverse events were noticed. CONCLUSIONS: The opioid-free anesthesia protocol improved quality of recovery after major elective surgery in a statistically but not clinically significant manner when compared to standard anesthesia.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Léger M, Perrault T, Pessiot-Royer S, et al. Opioid-free Anesthesia Protocol on the Early Quality of Recovery after Major Surgery (SOFA Trial): A Randomized Clinical Trial. Anesthesiology. 2024. PMID: 37976460. doi:10.1097/ALN.0000000000004840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。